Announcement that Insmed has discontinued its internal development of INS-1, one of its investigational drug candidates for type 2 diabetes and polycystic ovary syndrome (PCOS). (September 10, 2002)
(Added:
31-Jan-2005
| Hits:
0
| Rating:
0
| Votes:
0
) Info |
Rate It
Pages Updated On:
10-Oct-2005
-
19:18:02
[an error occurred while processing this directive]
